chr14-28767768-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP5BA1
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Gly163= variant in FOXG1 is 0.09% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Gly163= variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Gly163= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA172185/MONDO:0100040/016
Frequency
Consequence
NM_005249.5 synonymous
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FOXG1 | ENST00000313071.7 | c.489C>T | p.Gly163Gly | synonymous_variant | Exon 1 of 1 | 6 | NM_005249.5 | ENSP00000339004.3 | ||
| FOXG1 | ENST00000706482.1 | c.489C>T | p.Gly163Gly | synonymous_variant | Exon 2 of 2 | ENSP00000516406.1 | ||||
| LINC01551 | ENST00000675861.1 | n.374+1755C>T | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 87AN: 150532Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000484 AC: 101AN: 208658 AF XY: 0.000540 show subpopulations
GnomAD4 exome AF: 0.000741 AC: 1049AN: 1414872Hom.: 0 Cov.: 37 AF XY: 0.000772 AC XY: 542AN XY: 701940 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000578 AC: 87AN: 150532Hom.: 0 Cov.: 32 AF XY: 0.000626 AC XY: 46AN XY: 73444 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
- -
- -
not provided Benign:2
FOXG1: BP4, BP7 -
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
FOXG1 disorder Benign:1
The allele frequency of the p.Gly163= variant in FOXG1 is 0.09% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Gly163= variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Gly163= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP5). -
FOXG1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Rett syndrome, congenital variant Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at